<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-pharmaceutics-13-00327">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kasper</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Muller</surname>
    <given-names>W.E.</given-names>
   </name>
   <name>
    <surname>Volz</surname>
    <given-names>H.P.</given-names>
   </name>
   <name>
    <surname>Moller</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Koch</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Dienel</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Silexan in anxiety disorders: Clinical data and pharmacological background</article-title>
  <source>World J. Biol. Psychiatry</source>
  <year>2018</year>
  <volume>19</volume>
  <fpage>412</fpage>
  <lpage>420</lpage>
  <pub-id pub-id-type="doi">10.1080/15622975.2017.1331046</pub-id>
  <pub-id pub-id-type="pmid">28511598</pub-id>
 </element-citation>
</ref>
